rVSVΔG-ZEBOV-GP
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for rVSVΔG-ZEBOV-GP, covering 2017-05-30 to 2023-04-20. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of the rVSVΔG-ZEBOV-GP Ebola Virus Vaccine Candidate in Children Living in Lambaréné, Gabon [Phase 1, Phase 2]